Release Date: 2024-06-07

Natural Antioxidant Inhibitors: in Vitro Evaluation of Anti-Epileptic, Anti-Alzheimer’s Disease and Anti-Diabetic Agents (2015-Present)

Nastaran Sadeghian (Author), Arslan Recep Sahin (Author), Parham Taslimi (Author)

Release Date: 2024-06-07

Natural antioxidant inhibitors act as precursors in the treatment of many metabolic diseases. Natural antioxidant inhibitors are especially important in the treatment of metabolic diseases such as Epilepsy, Diabetes and Alzheimer’s. Therefore, in this chapter, natural antioxidant inhibitors and their effects on metabolic diseases are explained with current scientific studies. It is anticipated that this [...]

Media Type
    Buy from

    Price may vary by retailers

    Work TypeBook Chapter
    Published inNatural Antioxidants and in Vitro Antioxidant Assays
    First Page43
    Last Page70
    DOIhttps://doi.org/10.69860/nobel.9786053359333.3
    Page Count28
    Copyright HolderNobel Tıp Kitabevleri
    Licensehttps://nobelpub.com/publish-with-us/copyright-and-licensing

    Natural antioxidant inhibitors act as precursors in the treatment of many metabolic diseases. Natural antioxidant inhibitors are especially important in the treatment of metabolic diseases such as Epilepsy, Diabetes and Alzheimer’s. Therefore, in this chapter, natural antioxidant inhibitors and their effects on metabolic diseases are explained with current scientific studies. It is anticipated that this study will be a reference for many scientific studies.

    Arslan Recep Sahin (Author)
    MD, Bartin University
    https://orcid.org/0000-0001-5593-6795
    3The author graduated from Bartın University from Department of Biotechnology.He focused on the basic and current issues of biochemistry in his academic studies. His most important studies are related to the antioxidant activities of molecules and herbal extracts obtained from natural sources or through synthesis.

    Nastaran Sadeghian (Author)
    PhD, Asst. Prof. Dr., Bartin University
    https://orcid.org/0000-0002-2913-4614
    3The author graduated from Islamic Azad University, Faculty of Science in 2009, which started in 2005. In 2012, he completed his master’s degree in the anorganic chemistry at the same university, with a thesis subject "Synthesis of nanomagnetic." He graduated his doctorate at Ataturk University, Faculty of Science, in the Biochemistry program.astaran SADEGHIAN focused on the basic and current issues of biochemistry in her academic studies. Her most important studies are related to the antioxidant activities of molecules and herbal extracts obtained from natural sources or through synthesis. These studies were published in journals with a very high impact factor. In addition to candidate antioxidant activity studies, She also conducts studies on the purification and characterization of some metabolic enzymes and the design and synthesis of inhibitors for these enzymes. In this very current field, carbonic anhydrase isoenzymes, which are associated with disorders such as glaucoma, cancer, epilepsy, ulcer and osteoporosis, acetylcholinesterase and butyrylcholinesterase enzymes, which have an important place in the cholinergic hypothesis and are associated with many neurodegenerative diseases such as Alzheimer’s disease, and α-glucosidase, which is associated with diabetes. He carries out studies on the purification and characterization of digestive enzymes such as and α-amylase, and the design and synthesis of new inhibitors for these enzymes. He made up-to-date approaches on druggability properties by supporting the inhibition types and mechanisms of action of molecules with known inhibition properties on these candidate enzymes with molecular modeling (docking) studies.

    Parham Taslimi (Author)
    PhD, Assoc. Prof. Dr., Bartin University
    https://orcid.org/0000-0002-3171-0633
    3The author graduated from Islamic Azad University, Faculty of Science in 2010, which started in 2006. In 2013, he completed his master’s degree in the Molecular Biology and Genetics at the Ataturk university, with a thesis subject "Termostable enzyme" He graduated his doctorate at Ataturk University, Faculty of Science, in the Biochemistry program.Parham TASLIMI focused on the basic and current issues of biochemistry in his academic studies. His most important studies are related to the antioxidant activities of molecules and herbal extracts obtained from natural sources or through synthesis. These studies were published in journals with a very high impact factor. In addition to candidate antioxidant activity studies, he also conducts studies on the purification and characterization of some metabolic enzymes and the design and synthesis of inhibitors for these enzymes. In this very current field, carbonic anhydrase isoenzymes, which are associated with disorders such as glaucoma, cancer, epilepsy, ulcer and osteoporosis, acetylcholinesterase and butyrylcholinesterase enzymes, which have an important place in the cholinergic hypothesis and are associated with many neurodegenerative diseases such as Alzheimer’s disease, and α-glucosidase, which is associated with diabetes. He carries out studies on the purification and characterization of digestive enzymes such as and α-amylase, and the design and synthesis of new inhibitors for these enzymes. He made up-to-date approaches on druggability properties by supporting the inhibition types and mechanisms of action of molecules with known inhibition properties on these candidate enzymes with molecular modeling (docking) studies.

    • E. (2023). Bazı Arı Ürünlerinin (Bal, Polen, Propolis, Arı Sütü ve Arı Ekmeği) LC-MS/MS ile Sekonder Metabolitlerinin ve Biyolojik Aktivitelerinin Belirlenmesi. Doktora tezi. Atatürk Üniversitesi Fen Bilimleri Enstitüsü, Erzurum

    • Yılmaz, M.A., Cakir, O., İzol, E., Tarhan, A., Behçet, L., Zengin, G. (2023). Detailed Phytochemical Evaluation of a Locally Endemic Species (Campanula baskilensis) by LC-MS/MS and its In-Depth Antioxidant and Enzyme Inhibitory Activities. Chemistry&Biodiversity, 20(12), e202301182.

    • Karageçili, H., İzol, E., Kireçci, E. & Gülçin, İ. (2023). Antioxidant, antidiabetic, antiglaucoma, and anticholinergic effects of Tayfi grape (Vitis vinifera): A phytochemical screening by LC-MS/MS analysis. Open Chemistry, 21(1), 20230120.

    • Inci, H., Izol, E., Yilmaz, M. A., Ilkaya, M., Bingöl, Z., & Gülçin, I. (2023). Comprehensive Phytochemical Content by LC/MS/MS and Anticholinergic, Antiglaucoma, Antiepilepsy, and Antioxidant Activity of Apilarnil (Drone Larvae). Chemistry & Biodiversity, 20(10), e202300654.

    • Karagecili, H., Izol, E., Kirecci, E., Gulcin, I. (2023). Determination of Antioxidant, Anti-Alzheimer, Antidiabetic, Antiglaucoma and Antimicrobial Effects of Zivzik Pomegranate (Punicagranatum) —A Chemical Profiling by LC-MS/MS). Life, 13, 735.

    • Flieger, J., Flieger, W., Baj, J., & Maciejewski, R. (2021). Antioxidants: Classification, natural sources, activity/capacity measurements, and usefulness for the synthesis of nanoparticles. Materials, 14(15), 4135.

    • Bursal, E., Yılmaz, M. A., Izol, E., Türkan, F., Atalar, M. N., Murahari, M., ... &Ahmad, M. (2021). Enzyme inhibitory function and phytochemical profile of Inula discoidea using in vitro and in silico methods. Biophysical Chemistry, 277, 106629.

    • Izol, E., Temel, H., Yilmaz, M. A., Yener, I., Olmez, O. T., Kaplaner, E., ... &Ertas, A. (2021). A detailed chemical and biological investigation of twelve Allium species from Eastern Anatolia withchemometric studies. Chemistry&Biodiversity, 18(1), e2000560.

    • Izol, E. (2016). Determination of Heavy Metals and Seconder Metabolites of some Allium (Wild Garlic) Species by ICP-MS and LC-MS/ MS Investigation of Their Biological Activities. Dicle Üniversitesi, Fen Bil. Ens., Kimya ABD, Yüksek Lisans Tezi.

    • Ciccone, L., Cerri, C., Nencetti, S., & Orlandini, E. (2021). Carbonic anhydrase inhibitors and epilepsy: State of the art and future perspectives. Molecules, 26(21), 6380.

    • Çelik, T. (2018). Bazı doğal maddelerin insan karbonik anhidraz I ve II izoenzimleri üzerindeki inhibitör etkilerinin incelenmesi (Master's thesis, Fen Bilimleri Enstitüsü).

    • DiMario, R. J., Machingura, M. C., Waldrop, G. L., & Moroney, J. V. (2018). The many types of carbonic anhydrases in photosynthetic organisms. Plant science, 268, 11-17.

    • Supuran, C. T. (2016). Structure and function of carbonic anhydrases. Biochemical Journal, 473(14), 2023-2032.

    • Del Prete, S., De Luca, V., Supuran, C. T., & Capasso, C. (2015). Protonography, a technique applicable for the analysis of η-carbonic anhydrase activity. Journal of enzyme inhibition and medicinal chemistry, 30(6), 920-924.

    • Taslimi, P., Gulcin, I., Ozgeris, B., Goksu, S., Tumer, F., Alwasel, S. H., & Supuran, C. T. (2016). The human carbonic anhydrase isoenzymes I and II (hCA I and II) inhibition effects of trimethoxyindane derivatives. Journal of enzyme inhibition and medicinal chemistry, 31(1), 152-157.

    • Supuran, C. T. (2018). Carbonic anhydrase activators. Future medicinal chemistry, 10(5), 561-573.

    • Supuran, C. T. (2020). Coumarin carbonic anhydrase inhibitors from natural sources. Journal of Enzyme Inhibition and Medicinal Chemistry, 35(1), 1462-1470.

    • Scozzafava, A., Passaponti, M., Supuran, C. T., & Gülçin, İ. (2015). Carbonic anhydrase inhibitors: guaiacol and catechol derivatives effectively inhibit certain human carbonic anhydrase isoenzymes (hCA I, II, IX and XII). Journal of enzyme inhibition and medicinal chemistry, 30(4), 586-591.

    • Chambers, H. F., & Jawetz, E. (1998). Sulfonamides, Trimethoprim and Quinolones, in Basic and Clinical Pharmacology. Appleton-Lange, 7, 761-763.

    • Supuran, C. T. (2017). sulfonamides. Molecules, 22(10), 1642.

    • Thapa, S., Lv, M., & Xu, H. (2017). Acetylcholinesterase: a primary target for drugs and insecticides. Mini reviews in medicinal chemistry, 17(17), 1665-1676.

    • Košak, U., Brus, B., Knez, D., Šink, R., Žakelj, S., Trontelj, J., ... & Gobec, S. (2016). Development of an in-vivo active reversible butyrylcholinesterase inhibitor. Scientific reports, 6(1), 39495.

    • Saxena, M., & Dubey, R. (2019). Target enzyme in Alzheimer’s disease: Acetylcholinesterase inhibitors. Current topics in medicinal chemistry, 19(4), 264-275.

    • Akdeniz, Ö. (2019). Asetilkolinesteraz ve butirilkolinesteraz enzimleri üzerinde bazı pestisitlerin etkilerinin incelenmesi (Master's thesis, Fen Bilimleri Enstitüsü).

    • Thapa, S., Lv, M., & Xu, H. (2017). Acetylcholinesterase: a primary target for drugs and insecticides. Mini reviews in medicinal chemistry, 17(17), 1665-1676.

    • Patel, S. S., Raghuwanshi, R., Masood, M., Acharya, A., & Jain, S. K. (2018). Medicinal plants with acetylcholinesterase inhibitory activity. Reviews in the Neurosciences, 29(5), 491-529.

    • Ha, Z. Y., Mathew, S., & Yeong, K. Y. (2020). Butyrylcholinesterase: a multifaceted pharmacological target and tool. Current Protein and Peptide Science, 21(1), 99-109.

    • Zhou, S., & Huang, G. (2022). The biological activities of butyrylcholinesterase inhibitors. Biomedicine & Pharmacotherapy, 146, 112556.

    • Delacour, H., Dedome, E., Courcelle, S., Hary, B., & Ceppa, F. (2016, June). Butyrylcholinesterase deficiency. In Annales de Biologie Clinique (Vol. 74, No. 3, pp. 279-285).

    • Ozgun, D. O., Yamali, C., Gul, H. I., Taslimi, P., Gulcin, I., Yanik, T., & Supuran, C. T. (2016). Inhibitory effects of isatin Mannich bases on carbonic anhydrases, acetylcholinesterase, and butyrylcholinesterase. Journal of enzyme inhibition and medicinal chemistry, 31(6), 1498-1501.

    • Sharma, K. (2019). Cholinesterase inhibitors as Alzheimer's therapeutics. Molecular medicine reports, 20(2), 1479-1487.

    • Velander, P., Wu, L., Henderson, F., Zhang, S., Bevan, D. R., & Xu, B. (2017). Natural product-based amyloid inhibitors. Biochemical pharmacology, 139, 40-55.

    • Lin, Y. T., Chou, M. C., Wu, S. J., & Yang, Y. H. (2019). Galantamine plasma concentration and cognitive response in Alzheimer’s disease. PeerJ, 7, e6887.

    • Li, Q., He, S., Chen, Y., Feng, F., Qu, W., & Sun, H. (2018). Donepezil-based multi-functional cholinesterase inhibitors for treatment of Alzheimer's disease. European journal of medicinal chemistry, 158, 463-477.

    • Ray, B., Maloney, B., Sambamurti, K., Karnati, H. K., Nelson, P. T., Greig, N. H., & Lahiri, D. K. (2020). Rivastigmine modifies the α-secretase pathway and potentially early Alzheimer’s disease. Translational Psychiatry, 10(1), 47.

    • Chen, T. H., Chou, M. C., Lai, C. L., Wu, S. J., Hsu, C. L., & Yang, Y. H. (2017). Factors affecting therapeutic response to Rivastigmine in Alzheimer's disease patients in Taiwan. The Kaohsiung journal of medical sciences, 33(6), 277-283.

    • Birks, J. S., & Evans, J. G. (2015). Rivastigmine for Alzheimer's disease. Cochrane Database of systematic reviews, (4).

    • J Meneses, M., M Silva, B., Sousa, M., Sá, R., F Oliveira, P., & G Alves, M. (2015). Antidiabetic drugs: mechanisms of action and potential outcomes on cellular metabolism. Current pharmaceutical design, 21(25), 3606-3620.

    • Fisman, E. Z., & Tenenbaum, A. (2015). Antidiabetic treatment with gliptins: focus on cardiovascular effects and outcomes. Cardiovascular diabetology, 14(1), 1-13.

    • Taslimi, P., & Gulçin, İ. (2017). Antidiabetic potential: In vitro inhibition effects of some natural phenolic compounds on α‐glycosidase and α‐amylase enzymes. Journal of Biochemical and Molecular Toxicology, 31(10), e21956.

    • Alqahtani, A. S., Hidayathulla, S., Rehman, M. T., ElGamal, A. A., Al-Massarani, S., Razmovski-Naumovski, V., ... & AlAjmi, M. F. (2019). Alpha-amylase and alpha-glucosidase enzyme inhibition and antioxidant potential of 3-oxolupenal and katononic acid isolated from Nuxia oppositifolia. Biomolecules, 10(1), 61.

    • Assefa, S. T., Yang, E. Y., Chae, S. Y., Song, M., Lee, J., Cho, M. C., & Jang, S. (2019). Alpha glucosidase inhibitory activities of plants with focus on common vegetables. Plants, 9(1), 2.

    • Santos, C. M., Freitas, M., & Fernandes, E. (2018). A comprehensive review on xanthone derivatives as α-glucosidase inhibitors. European Journal of Medicinal Chemistry, 157, 1460-1479.

    • Leroux‐Stewart, J., Rabasa‐Lhoret, R., & Chiasson, J. L. (2015). α‐Glucosidase inhibitors. International textbook of diabetes mellitus, 673-685.

    • Tiwari, S. P., Srivastava, R., Singh, C. S., Shukla, K., Singh, R. K., Singh, P., ... & Sharma, R. (2015). Amylases: an overview with special reference to alpha amylase. J Global Biosci, 4(1), 1886-1901.

    • Zhang, Q., Han, Y., & Xiao, H. (2017). Microbial α-amylase: a biomolecular overview. Process Biochemistry, 53, 88-101.

    • Agarwal, P., & Gupta, R. (2016). Alpha-amylase inhibition can treat diabetes mellitus. Res. Rev. J. Med. Health Sci, 5(4), 1-8.

    • Damaris, R. N., Lin, Z., Yang, P., & He, D. (2019). The rice alpha-amylase, conserved regulator of seed maturation and germination. International journal of molecular sciences, 20(2), 450.

    • Jhong, C. H., Riyaphan, J., Lin, S. H., Chia, Y. C., & Weng, C. F. (2015). S creening alpha‐glucosidase and alpha‐amylase inhibitors from natural compounds by molecular docking in silico. Biofactors, 41(4), 242-251.

    • Berktaş, S., & Mustafa, Ç. A. M. (2020). İğde (Elaeagnus angustifolia L.) meyve ve yapraklarının antioksidan ve antidiyabetik özellikleri. Akademik Gıda, 18(3), 270-278.

    • Oboh, G., Ogunsuyi, O. B., Ogunbadejo, M. D., & Adefegha, S. A. (2016). Influence of gallic acid on α-amylase and α-glucosidase inhibitory properties of acarbose. journal of food and drug analysis, 24(3), 627-634.

    • Murat, Z. O. R., Pekacar, S., & Orhan, D. D. (2022). Nasturtium offıcınale’nin fitokimyasal içeriği, antioksidan ve enzim inhibitör etkileri. Journal of Faculty of Pharmacy of Ankara University, 46(1), 114-128.

    onix_3.0::thothThoth ONIX 3.0
    onix_3.0::project_museProject MUSE ONIX 3.0
    onix_3.0::oapenOAPEN ONIX 3.0
    onix_3.0::jstorJSTOR ONIX 3.0
    onix_3.0::google_booksGoogle Books ONIX 3.0
    onix_3.0::overdriveOverDrive ONIX 3.0
    onix_2.1::ebsco_hostEBSCO Host ONIX 2.1
    csv::thothThoth CSV
    json::thothThoth JSON
    kbart::oclcOCLC KBART
    bibtex::thothThoth BibTeX
    doideposit::crossrefCrossRef DOI deposit
    onix_2.1::proquest_ebraryProQuest Ebrary ONIX 2.1
    marc21record::thothThoth MARC 21 Record
    marc21markup::thothThoth MARC 21 Markup
    marc21xml::thothThoth MARC 21 XML

    Share This Chapter!